Highbridge Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,474	Closed	-$567K	–	1286
2017 Q1	$567K	Sell	10,474 -2,071	-17%	-$108K	0.01%	842
2016 Q4	$666K	Sell	12,545 -1,379	-10%	-$78.4K	0.01%	670
2016 Q3	$844K	Buy	+13,924	New	+$867K	0.01%	617
2015 Q4	–	Sell	-1,931	Closed	-$305K	–	1529
2015 Q3	$305K	Buy	+1,931	New	+$547K	﹤0.01%	1226
2014 Q4	–	Sell	-1,169	Closed	-$291K	–	1195
2014 Q3	$227K	Buy	+1,169	New	+$255K	﹤0.01%	1076
2014 Q2	–	Sell	-3,633	Closed	-$820K	–	1078
2014 Q1	$963K	Buy	3,633 +2,214	+156%	+$848K	0.01%	561
2013 Q4	$516K	Buy	+1,419	New	+$547K	0.01%	668
2013 Q3	–	Sell	-862	Closed	-$202K	–	1290
2013 Q2	$202K	Buy	+862	New	+$170K	﹤0.01%	1184